All News
Filter News
Found 808,979 articles
-
Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients
3/21/2019
Viome announces it will collaborate with precision health leader, Helomics, to study the link between the gut microbiome and ovarian cancer.
-
Mogrify wins Business Weekly award for ‘Disruptive Technology’
3/21/2019
Cell Mogrify Ltd (Mogrify), a UK company aiming to transform the future development of cell therapies, has won the ‘Disruptive Technology’ category at the Business Weekly Awards, in recognition of its novel bioinformatic platform, which is built upon a decade of world-class multidisciplinary science.
-
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer's Disease
3/21/2019
Discontinued aducanumab phase 3 studies emphasize urgent need for therapies that target the toxic oligomer with exacting precision
-
Local Austin Dentists Offering the Lowest Price Dental Crowns, Veneers and Bridges in the Country
3/21/2019
Simply Crowns, established in 2017, was started by Dr. Ben Poest to save Texans millions of dollars in dental fees.
-
Versant Health releases white paper: The medical advantage of an annual eye exam
3/21/2019
Blindness ranks as one of the top fears of aging Americans, along with stroke, Alzheimer's disease, diabetes, and heart disease.
-
Covenant Care California, LLC Notice of Data Privacy Incident - March 20, 2019
3/21/2019
Covenant Care California, LLC, provides supportive and resource services to certain affiliated licensed nursing facilities.
-
Teva Selects Genedata Biologics to Support Next-generation Biopharmaceuticals R&D
3/21/2019
Genedata Biologics® streamlines Teva’s R&D workflows and increases operational efficiency
-
Health Quest Sets out to Boost Participation in Clinical Trials with IBM Watson
3/21/2019
Use of IBM Watson for Clinical Trial Matching Expands Health Quest's Use of AI
-
QBE North America Appoints Risk Lead to Support Dedicated Healthcare Team
3/21/2019
QBE North America announced the appointment of Theresa M. Zimmerman to the role of Global Risk Solutions Lead for the QBE Integrated Advantage for Healthcare.
-
Soft Tissue Sarcoma requires a multidisciplinary approach to reduce patient relapses and improve patient survival
3/21/2019
This weekend Madrid will host the 3rd edition of the world congress "Soft Tissue Sarcoma: Evidence and Experience", where oncologists and medical specialists from all over the world will meet to share the latest advances in the treatment and diagnosis of this disease, which accounts for less than 1% of adult cancers.
-
Varian Holds First Meeting of FlashForward Consortium
3/21/2019
Building on its market-leading efforts in preclinical research aimed at clinical implementation of Flash therapy, Varian hosted the first meeting of the FlashForward™ Consortium in Atlanta, Georgia on March 8-9.
-
AscellaHealth Supports Multiple Sclerosis Awareness Month, Provides High-Touch Specialty Pharmacy Solutions to Improve Outcomes, Lower Costs
3/21/2019
Multiple Sclerosis Association of America focuses 2019 awareness campaign on family, relationships and care partner needs
-
Kaiser Permanente Ranked Top Performing Health Plan
3/21/2019
Kaiser Permanente Washington's care and coverage combined model earned top ranking in the nation for helping members manage acute conditions and helping members manage chronic conditions.
-
Titan Medical Closes Public Offering
3/21/2019
Titan Medical Inc., a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, is pleased to announce the closing of its previously announced public offering pursuant to an agency agreement dated March 18, 2019 between the Company and Bloom Burton Securities Inc..
-
The Rite Aid Foundation, Attorney General Josh Shapiro and Pittsburgh Penguins Foundation Host Teacher Training for Prescription Drug Safety Program in Western Pennsylvania
3/21/2019
A year after the Prescription Drug Safety program was rolled out in high schools in Western Pennsylvania, The Rite Aid Foundation, the Office of the Attorney General and the Pittsburgh Penguins Foundation led a special training session for 50 additional teachers in Western Pennsylvania on the program, which is an innovative digital course about prescription drug abuse prevention.
-
CoolSculpting® and Sonja Morgan Talk Bikini Denial Just In Time For Summer
3/21/2019
CoolSculpting, owned by Allergan plc, is partnering once again with television personality on Bravo's "The Real Housewives of New York City", philanthropist and fashion lifestyle entrepreneur Sonja Morgan to help women prepare for warmer weather and banish their Bikini Denial this summer.
-
Arix Bioscience plc Notice of Results
3/21/2019
Arix Bioscience plc (LSE: ARIX), a global healthcare and life science company supporting medical innovation, will announce its annual results for the period ended 31 December 2018 on Thursday, 28 March 2019.
-
The approval of Zulresso marks the first and only treatment for postpartum depression (PPD) approved by the U.S. Food and Drug Administration.
-
The trial, which paired a checkpoint inhibitor and PARP inhibitor, was not likely to hit endpoints. It was the second ovarian cancer trial failure for the two companies in six months.
-
A new market research report by Clarivate Analytics, “Cortellis Drugs to Watch,” identified seven new drugs it believes will hit sales of $1 billion or more, the so-called “blockbuster” mark, by 2023.